Interstitial Lung Diseases of Unknown Cause: Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract

Ronald Crystal, Peter B. Bitterman, Stephen I. Rennard, Allan J. Hance, Brendan A. Keogh

Research output: Contribution to journalReview article

209 Citations (Scopus)

Abstract

Sarcoidosis Sarcoidosis is a multisystem granulomatous disease of unknown cause characterized by enhanced cellular immune processes at sites of involvement.36,53,59,152 Almost all organs can be affected by the disease, but the lower respiratory tract is the site most commonly associated with morbidity and mortality.152 At least 90 per cent of patients with sarcoidosis have pulmonary manifestations; 20 to 25 per cent of these patients have a permanent loss of lung function, and 5 to 10 per cent die from complications of the disease.153,154 Sarcoidosis is found throughout the world.152 153 154 155 In the industrialized nations, the prevalence varies by sex, geographic location.

Original languageEnglish
Pages (from-to)235-244
Number of pages10
JournalNew England Journal of Medicine
Volume310
Issue number4
DOIs
Publication statusPublished - 26 Jan 1984
Externally publishedYes

Fingerprint

Interstitial Lung Diseases
Sarcoidosis
Respiratory System
Inflammation
Pulmonary Sarcoidosis
Respiratory Tract Diseases
Geographic Locations
Developed Countries
Morbidity
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Interstitial Lung Diseases of Unknown Cause : Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract. / Crystal, Ronald; Bitterman, Peter B.; Rennard, Stephen I.; Hance, Allan J.; Keogh, Brendan A.

In: New England Journal of Medicine, Vol. 310, No. 4, 26.01.1984, p. 235-244.

Research output: Contribution to journalReview article

Crystal, Ronald ; Bitterman, Peter B. ; Rennard, Stephen I. ; Hance, Allan J. ; Keogh, Brendan A. / Interstitial Lung Diseases of Unknown Cause : Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract. In: New England Journal of Medicine. 1984 ; Vol. 310, No. 4. pp. 235-244.
@article{ce023fa7bc1048b1bf2e8eb16a4fdf55,
title = "Interstitial Lung Diseases of Unknown Cause: Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract",
abstract = "Sarcoidosis Sarcoidosis is a multisystem granulomatous disease of unknown cause characterized by enhanced cellular immune processes at sites of involvement.36,53,59,152 Almost all organs can be affected by the disease, but the lower respiratory tract is the site most commonly associated with morbidity and mortality.152 At least 90 per cent of patients with sarcoidosis have pulmonary manifestations; 20 to 25 per cent of these patients have a permanent loss of lung function, and 5 to 10 per cent die from complications of the disease.153,154 Sarcoidosis is found throughout the world.152 153 154 155 In the industrialized nations, the prevalence varies by sex, geographic location.",
author = "Ronald Crystal and Bitterman, {Peter B.} and Rennard, {Stephen I.} and Hance, {Allan J.} and Keogh, {Brendan A.}",
year = "1984",
month = "1",
day = "26",
doi = "10.1056/NEJM198401263100406",
language = "English",
volume = "310",
pages = "235--244",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Interstitial Lung Diseases of Unknown Cause

T2 - Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract

AU - Crystal, Ronald

AU - Bitterman, Peter B.

AU - Rennard, Stephen I.

AU - Hance, Allan J.

AU - Keogh, Brendan A.

PY - 1984/1/26

Y1 - 1984/1/26

N2 - Sarcoidosis Sarcoidosis is a multisystem granulomatous disease of unknown cause characterized by enhanced cellular immune processes at sites of involvement.36,53,59,152 Almost all organs can be affected by the disease, but the lower respiratory tract is the site most commonly associated with morbidity and mortality.152 At least 90 per cent of patients with sarcoidosis have pulmonary manifestations; 20 to 25 per cent of these patients have a permanent loss of lung function, and 5 to 10 per cent die from complications of the disease.153,154 Sarcoidosis is found throughout the world.152 153 154 155 In the industrialized nations, the prevalence varies by sex, geographic location.

AB - Sarcoidosis Sarcoidosis is a multisystem granulomatous disease of unknown cause characterized by enhanced cellular immune processes at sites of involvement.36,53,59,152 Almost all organs can be affected by the disease, but the lower respiratory tract is the site most commonly associated with morbidity and mortality.152 At least 90 per cent of patients with sarcoidosis have pulmonary manifestations; 20 to 25 per cent of these patients have a permanent loss of lung function, and 5 to 10 per cent die from complications of the disease.153,154 Sarcoidosis is found throughout the world.152 153 154 155 In the industrialized nations, the prevalence varies by sex, geographic location.

UR - http://www.scopus.com/inward/record.url?scp=0021365617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021365617&partnerID=8YFLogxK

U2 - 10.1056/NEJM198401263100406

DO - 10.1056/NEJM198401263100406

M3 - Review article

C2 - 6361563

AN - SCOPUS:0021365617

VL - 310

SP - 235

EP - 244

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -